Ascentage Pharma Group International AAPG
NASDAQ AAPG
$17.77 +0.41 (+2.38%)
As of: Sep 4, 2026 · 3:59 PM EDT

Ascentage Pharma Group International (AAPG) Goodwill & Intangibles (2023 - 2026)

Ascentage Pharma Group International (AAPG) posted quarterly Goodwill & Intangibles of $12.8 million for Q4 2025, down 8.84% year-over-year from $14.0 million in Q4 2024, and down 4.33% quarter-over-quarter from $13.4 million in Q2 2025.

Analysis

Ascentage Pharma Group International (AAPG) Goodwill & Intangibles (2023 - 2026) Analysis & Trends

Ascentage Pharma Group International's Goodwill & Intangibles history runs 4 years deep, the most recent figure standing at $12.8 million for Q4 2025.

  • In Q4 2025, Goodwill & Intangibles fell 8.84% year-over-year to $12.8 million; the TTM figure through Dec 2025 stood at $12.8 million (down 8.84% YoY), while the FY2025 annual figure was $12.6 million, down 10.03% from the prior year.
  • Goodwill & Intangibles for Q4 2025 stood at $12.8 million, down from $13.4 million in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $14.0 million in Q4 2024, with the low at $4.0 million in Q4 2022.
  • The 4-year median for Goodwill & Intangibles is $12.8 million (2025), against an average of $10.3 million.
  • The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles surged 94.77% in 2024, then declined 8.84% in 2025.
  • Ascentage Pharma Group International's Goodwill & Intangibles stood at $4.0 million in 2022, then surged by 78.82% to $7.2 million in 2023, then jumped by 94.77% to $14.0 million in 2024, then dropped by 8.84% to $12.8 million in 2025.
  • Business Quant data shows AAPG's Goodwill & Intangibles at $12.8 million in Q4 2025, $13.4 million in Q2 2025, and $14.0 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Ascentage Pharma Group International 1.57 Bn 1.29 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.14 Mn
Dec 31, 2025 12.78 Mn
Jun 30, 2025 13.23 Mn
Dec 31, 2024 14.02 Mn
Dec 31, 2023 15.30 Mn